EXPERIENCE YOU CAN TRUST

The firm specializes in complex, commercial litigation. The firm's principal, Joshua H. Grabar, has been involved in some of the largest class actions of the last two decades.
DEDICATION YOU CAN RELY ON

We take pride in providing effective and aggressive representation. Our reputation and history of success speaks for itself and drives lasting client relationships. We are here for you.
LET'S WORK TOGETHER

If you have suffered a financial loss as a result of securities fraud, price-fixing or consumer fraud, you can rest assured that we are on your side. If you are a business seeking to avoid unnecessary legal liability, or reduce the costs of compliance, we are your solution.
latest blog
Grabar Law Office Files Shareholder Derivative Complaint Against Officers and Directors of QuantumScape Corporation
By Grabar Law |
This stockholder derivative action is brought on behalf of QuantumScape against certain current and former members of the Company’s Board of Directors (the “Board”) and other QuantumScape executives (collectively, the “Individual Defendants”) and Volkswagen Group of America Investments, LLC (“VGA” and, together with the Individual Defendants, “Defendants”) for (a) making and/or authorizing false and misleading…
Read More Grabar Law Office Files Shareholder Derivative Complaint Against Officers and Directors of Intrusion, Inc.
By Grabar Law |
This stockholder derivative action is brought on behalf of Intrusion, Inc. against certain members of the Company’s Board of Directors (the “Board”) and Company Officers for breach of their fiduciary duties in issuing, causing to be issued, or permitting the issuance of materially false and misleading public statements concerning the Company’s computer network product, the…
Read More GRABAR LAW OFFICE INVESTIGATES POTENTIAL CLAIMS AGAINST OFFICERS AND DIRECTORS OF VOLTA, INC. (NYSE: VLTA)
By Grabar Law |
A federal securities fraud class action against complaint has been filed Against Volta, Inc. and certain of its officers and directors. The complaint alleges that from August 2, 2021 to March 28, 2022, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Volta had improperly accounted for restricted stock units issued…
Read More GRABAR LAW OFFICE INVESTIGATES POTENTIAL CLAIMS AGAINST OFFICERS AND DIRECTORS OF ODONATE THERAPEUTICS, INC. AFTER AN AGREEMENT IS REACHED TO SETTLE CLASS ACTION
By Grabar Law |
Odonate Therapeutics Inc. (OTC: ODTC) has agreed to pay $12.5 million to resolve a proposed securities class action in alleging the pharmaceutical company misled investors about the safety of a new drug for treating cancer. The lawsuit accused the company of making misleading statements and omissions about the development of tesetaxel. The amended complaint says…
Read More